3, 10, and 12a substituted tetracycline compounds
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Nov 2, 2010
Grant Date -
Dec 29, 2005
app pub date -
Feb 28, 2005
filing date -
Jul 12, 2002
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The present invention pertains to novel 3, 10, and/or 12a-substituted tetracycline compounds. These tetracycline compounds can be used to treat numerous tetracycline compound-responsive states, such as bacterial infections and neoplasms, as well as other known applications for minocycline and tetracycline compounds in general, such as blocking tetracycline efflux and modulation of gene expression.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully